The WHO pandemic agreement: why countries will not use compulsory licensing – and how to fix it
Summary box During the COVID-19 pandemic, despite rights to use compulsory licensing for overriding patents in health emergencies, most low-income and middle-income countries were unable to produce COVID-19 vaccines independently due to political pressures against compulsory licensing and lack of manufacturing know-how protected by trade secrets.
Authors
- WooJung Jon (ORCID: https://orcid.org/0000-0002-5911-4796)
Institutions
- Korea Advanced Institute of Science and Technology (KR)
Publication Details
- Journal
- BMJ Global Health
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1136/bmjgh-2025-020856
- Citations
- 1
- Primary Topic
- Intellectual Property and Patents
- Type
- article
- Field-Weighted Citation Impact
- 2.76
Funders
- Korea Advanced Institute of Science and Technology
- Ministry of Science and ICT, South Korea